Precision cancer genome testing needs proficiency testing involving all stakeholders

To implement precision oncology, analytical validity as well as clinical validity and utility are important. However, proficiency testing (PT) to assess validity has not yet been systematically performed in Japan. To investigate the quality of next-generation sequencing (NGS) platforms and cancer ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Maekawa, Masato, Taniguchi, Terumi, Nishio, Kazuto, Sakai, Kazuko, Matsushita, Kazuyuki, Nakatani, Kaname, Ishige, Takayuki, Ikejiri, Makoto, Nishihara, Hiroshi, Sunami, Kuniko, Yatabe, Yasushi, Hatanaka, Kanako C., Hatanaka, Yutaka, Yamamoto, Yoshihiro, Fukuyama, Keita, Oda, Shinya, Saito, Kayoko, Yokomura, Mamoru, Kubo, Yuji, Sato, Hiroko, Tanaka, Yoshinori, Fuchioka, Misa, Yamasaki, Tadashi, Matsuda, Koichiro, Kurachi, Kiyotaka, Funai, Kazuhiro, Baba, Satoshi, Iwaizumi, Moriya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795413/
https://www.ncbi.nlm.nih.gov/pubmed/35087199
http://dx.doi.org/10.1038/s41598-022-05589-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795413/
https://www.ncbi.nlm.nih.gov/pubmed/35087199
http://dx.doi.org/10.1038/s41598-022-05589-x

Ejemplares similares